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Abstract
In 2014 the highest annual case count of Crimean-Congo hemorrhagic fever (CCHF) was
detected in Georgia since surveillance began in 2009. CCHF is a high-fatality hemorrhagic
syndrome transmitted by infected ticks and animal blood. In response to this immediate
public health threat, we assessed CCHF risk factors, seroprevalence, and CCHF-related
knowledge, attitudes, and practices in the 12 rural villages reporting a 2014 CCHF case, to
inform CCHF prevention and control measures. Households were randomly selected for
interviewing and serum sample collection. Data were weighted by non-response and gen-
der; percentages reflect weighting. Among 618 respondents, median age was 54.8 years
(IQR: 26.5, range: 18.6–101.4); 215 (48.8%) were male. Most (91.5%) participants reported
1 CCHF high-risk activity. Of 389 participants with tick exposure, 286 (46.7%) participants
handled ticks bare-handed; 65/216 (29.7%) knew the risk. Of 605 respondents, 355
(57.9%) reported animal blood exposure; 32/281 (12.7%) knew the risk. Of 612 responding,
184 (28.8%) knew protective measures against CCHF and tick exposures, but only 54.3%
employed the measures. Of 435 serum samples collected, 12 were anti-CCHF IgG positive,
indicating a weighted 3.0% seroprevalence. Most (66.7%) seropositive subjects reported
tick exposure. In these villages, CCHF risk factors are prevalent, while CCHF-related knowl-
edge and preventive practices are limited; these findings are critical to informing public
health interventions to effectively control and prevent ongoing CCHF transmission. Addi-
tionally, CCHF seroprevalence is higher than previously detected (0.03%), highlighting the
importance of this disease in the South Caucuses and in supporting ongoing regional
investigations.
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Introduction
Crimean-Congo hemorrhagic fever (CCHF) is a zoonotic, viral disease of the Bunyaviridae
family, primarily transmitted by the Hyalomma tick [1]. Transmission occurs from the bite of
an infected tick or from crushing an infected tick with bare skin. Secondary transmission has
been reported from contact with infected animal blood or tissues, or by ingesting unpasteurized
milk. Human-to-human transmission can occur from exposure to infected blood or bodily flu-
ids; however, this is typically reported in healthcare settings [2].
Although animals and ticks do not exhibit clinical signs of CCHF infection, about one out of
five humans infected with the virus develop clinically overt illness [3]. In humans the disease
presents as a non-specific febrile illness that can rapidly progress into a hemorrhagic syndrome,
leading to multi-organ failure and death in severe cases. The reported case fatality rate has varied
from 5% to 60% [1, 2, 4–7]. CCHF’s clinical severity, transmissibility, and infectiousness are
responsible for its categorization by the National Institute of Allergy and Infectious Diseases as a
Biodefense Category A pathogen, the highest risk to national security and public health [8].
Located in the South Caucuses, the country of Georgia is surrounded by neighboring coun-
tries where CCHF transmission is endemic [4, 9, 10]. Almost half the population of Georgia
resides in rural regions and is employed in agrarian activities, which may put them at risk for
CCHF [11]. CCHF surveillance started in Georgia in 2009, when the disease reporting tool, the
Electronic Integrated Disease Surveillance System (EIDSS), was established nationally. EIDSS
is used as part of the national surveillance system to report notifiable diseases; CCHF reporting
occurs when physicians at Georgian healthcare facilities suspect a patient of having CCHF and
report this through EIDSS, which alerts the Georgian National Center for Disease Control and
Public Health. EIDSS detected a median of one CCHF case per year (range: 0–13 cases) from
2009 to 2013, totaling 15 cases during that time period. A case was defined as fever (tempera-
ture>100.4°F [>38°C]), one or more hemorrhagic signs (petechial or purpural rash, bleeding,
or thrombocytopenia) and laboratory confirmation (i.e. a positive test for CCHF nucleic acid
or anti-CCHF IgM).
From January to September 2014, the surveillance system detected 22 cases of CCHF, the
highest annual case count since surveillance began in 2009 [12, 13]. Seventeen (77.3%) case-
patients were residents of rural villages. EIDSS had previously only detected three cases in
these same villages from 2009–2013, a CCHF prevalence of only 0.03%, based on the 2002
Georgian census reporting a population of 11,925 people in these specific villages. Most
(77.3%) case-patients were able to identify a known CCHF risk factor preceding their illness,
citing tick exposures and/or animal blood exposures [14]. Beyond the 22 cases detected, the
extent of CCHF transmission, as well as the CCHF risk factors in the villages reporting a 2014
CCHF case, were unknown. In fact, the previously low annual CCHF case counts limited large-
scale CCHF investigations in Georgia to date, rendering the overall burden of CCHF and asso-
ciated risk factors in Georgia unknown. Thus, data to inform immediate public health inter-
ventions in these communities were limited. In the rural villages reporting at least one 2014
CCHF case, we launched an investigation to determine CCHF seroprevalence, identify risk fac-
tors, and document CCHF-related knowledge, attitudes, and practices (KAP). Ultimately, the
goal was to use this data to direct immediate public health interventions in order to mitigate
CCHF risk and transmissibility in these communities, as well as to inform future prevention
and response efforts in the country of Georgia.
Materials and Methods
We conducted a knowledge, attitudes and practices (KAP) and risk factor survey (referred to as
the KAP/risk factor survey), as well as a CCHF serosurvey in the 12 affected rural villages,
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defined as villages with at least one CCHF case reported from January to September 2014 (Fig
1). Participants could enroll in the KAP/risk factor survey, the serosurvey, or both. The survey
was administered over a one-week period in October 2014.
Investigation Population
All available adult household members in the selected households who met the inclusion crite-
ria were identified and enrolled. Inclusion criteria included 1) an adult (18 years old) member
of the household who could give consent and 2) resident of the household or village for the pre-
ceding two months to ensure that any anti-CCHF IgM positivity would correspond to the
selected village. Exclusion criteria included CCHF symptoms at the time of the interview, age
less than 18 years, not having lived in the village or in the household for the preceding two
months, and not being able to give consent.
Sample Size
We calculated a total sample size of 905 participants or 457 households by allocating the sam-
ple size for each village proportional to the population size based on the 2002 Georgian census
and on the following assumptions: 1) alpha is 0.05 (95% confidence interval), 2) CCHF sero-
prevalence is 2.7% ± 5%, based on data reported from endemic countries [4, 9, 10, 15–17], 3)
design effect of 1, assuming minimal household clustering, 4) response rate of 90%, and 5)
adult household size of at least two [18].
Fig 1. The 12 rural villages reporting at least one Crimean-Congo hemorrhagic fever (CCHF) case from January to September 2014 in Georgia.
Georgia is demarcated in white with surrounding countries in gray. The capital, Tbilisi, is indicated by a star. The black squares denote the villages that had at
least one CCHF case reported in the Electronic Integrated Disease Surveillance System from January to September 2014. Map adapted from
MapsOpenSource.com.
doi:10.1371/journal.pone.0158049.g001
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Investigation Design
Using Google EarthTM (Version 7.1.2.2041, Google Inc., Mountain View, CA, USA) satellite
imagery of the 12 affected villages, rooftops were enumerated. Using a random number genera-
tor, we randomly selected rooftops and recorded their global positioning system (GPS) coordi-
nates. In the field, survey teams used GPS mobile devices (2007, Garmin Ltd., Olathe, KS,
USA) to locate the selected structures [19]. Each selected structure was categorized as a house-
hold, an abandoned house, a summer house (defined as a secondary house that is usually only
inhabited during the summer months), or not a house (e.g. commercial property, church, barn,
etc.). If the assigned rooftop was not a house, or was confirmed by neighbors to be an aban-
doned house or a summer house, the next proximal house to the right that met the household
definition was selected.
KAP/risk factor survey. The KAP/risk factor survey was translated into Kartuli, the most
commonly spoken language in Georgia, and then back translated into English by another
translator. Any discrepancies were discussed between the two translators. Five people under-
went pilot testing of the questionnaire: two had background and understanding of the daily
practices in the affected villages to ensure answer choices were appropriate and culturally sensi-
tive, while the other three’s highest education level was secondary school or less, to ensure the
language of the survey could be understood at the secondary education level. Changes were
made to ensure terminology was culturally appropriate, less scientific, and that the answer
choices accurately reflected the daily activities in the rural villages (SI Survey). The question-
naire was also translated in Azeri for the one Azerbaijani village investigated.
The KAP/risk factor survey was administered verbally to participants based on their pre-
ferred language (Kartuli or Azeri) by interviewers fluent in the language. The survey instru-
ment contained questions regarding demographics, CCHF risk factors, CCHF-related
knowledge, attitudes, and practices, history of illness in the last four months, and symptoms of
fever and hemorrhage in the last five years. At the conclusion of the interview, households
received educational material regarding CCHF infection and preventive practices, as well as
contact information for the local public health center.
Serosurvey. For participants consenting to the serosurvey, a sample of 10 ml whole blood
was obtained from each willing participant for CCHF serological testing. Serologic testing was
performed at the R. G. Lugar Center for Public Health Research (Tbilisi, Georgia) for recent
(within the past four months) and past (within last five years) CCHF infection as demonstrated
by anti-CCHF IgM and IgG, respectively [1]. Testing was performed using the commercially
available CCHF virus IgM and IgG enzyme-linked immunosorbent assay (ELISA) kits (Vec-
tor-Best Company, Novosibirsk, Russia) according to manufacturer’s instructions [20]. All
testing was performed in duplicate. The negative control wells’mean optical density plus 0.2
produced the cutoff value for the assay. A positive sample was defined as an absorbance value
higher than the calculated cutoff value, per manufacturer’s instructions. If any sample was
found to be anti-CCHF IgM positive, reverse transcriptase-polymerase chain reaction
(RT-PCR) was performed.
Data Analysis
KAP/risk factor survey responses were de-identified and entered into a database (EpiInfoTM,
version 7.1.1.14, CDC, Atlanta, GA, USA). Double data entry was performed by two different
investigators. We randomly selected 10% of records entered in the database for review to
ensure proper data entry by comparison with the original questionnaire.
Both serologic and KAP/risk factor survey data were analyzed using EpiInfoTM and SAS
(Version 9.3, SAS Institute Inc., Cary, NC, USA). KAP data and the overall seroprevalence
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calculation were weighted for non-response as well as gender by each village, using Georgia’s
2002 national census data on male to female ratios in the affected villages. Two participants
had missing answers for the gender question and thus, data were imputed based on male to
female ratios in other households; percentages presented reflect the weighting. The serosurvey
data were analyzed unweighted.
Answers to the knowledge questions were scored as correct or incorrect, based on evidence
from the literature. For risk factor analysis, high-risk activities were evaluated based on known
CCHF vectors as well as previously known activities of daily living/practices in the affected vil-
lages, including: animal husbandry, herding, exposure to ticks, butchering raw meat, slaughter-
ing, assisting in animal births, drinking unpasteurized milk, working in a healthcare setting,
and involvement in agriculture [1–3, 6, 15–17, 21] (S1 Survey). Thus, a participant could be
involved in a maximum of nine high-risk activities. Animal blood exposure was defined as
assisting with animal births, slaughtering and/or butchering animals. Tick exposure was
defined as any interaction with ticks including direct physical contact, bites, as well as exposure
to ticks around the work and/or home environment.
Bivariate testing was performed using Chi-square analysis to evaluate frequencies between
variables, and the Mann-Whitney U test to analyze medians. For comparison of three or more
groups, the Kruskal Wallis Test was used. Significance was set at a p-value greater than 0.05.
Ethical Review
Written informed consent was obtained from all participants. No personal identifying infor-
mation was included. This investigation was reviewed in accordance with United States Cen-
ters for Disease Control and Prevention human subjects review procedures and was
determined to be a non-research public health response activity.
Results
KAP/risk factor survey
During the one week of data collection, the investigative team visited 453 houses; occupants
were not home in 26 (5.8%) houses. A total of 657 people (1.5 people per household) were
approached for enrollment: 14 (2.1%) were not eligible, 17 (2.6%) refused to participate, and
one (0.1%) did not complete the questionnaire. Additionally, seven questionnaires went miss-
ing in the field. Thus, we conducted a total of 618 completed interviews (1.4 participants per
household).
Of the 618 participants surveyed, 215 (48.8%) were male. Median respondent age was 54.8
years (IQR 26.5, range: 18.6–101.4). Most (47.1%) participants reported an agrarian occupa-
tion. Of 617 responding, 54.6% participants’ highest completed education level was secondary
school. Of 616 responding, 73.9% participants had income less than 500 Lari per month
(approximately 250 US Dollars). Additionally, of 612 participants, 355 (55.8%) owned less
than 2,001m2 of land (Table 1).
Of 593 respondents, 429 (71.3%) had heard of CCHF previously. Most (81.1%) participants
reported hearing about CCHF through media avenues; of these, 306 (89.1%) cited a television
source. Of 429 participants responding to the knowledge questions, 348 (79.5%) were able to
correctly identify at least one mode of CCHF transmission; most (74.8%) identified a tick bite.
Most (80.3%) participants were able to correctly identify a CCHF risk activity, citing working
with livestock as the most common (73.1%). Those with CCHF high-risk activity knowledge
were more likely to be engaged in those activities than other surveyed (OR: 2.7, CI: 1.2–6.2,
p = 0.0140). Additionally, most (65.7%) participants were able to correctly report at least one
sign or symptom of CCHF; of those, 95.5% identified fever, 48.9% headache, and 41.2% nausea
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and vomiting. Of 612 responding, 184 (28.8%) knew correct protective measures against
CCHF and tick exposures; of those, 102 (54.3%) employed the protective measures (Table 2).
In terms of attitudes, 359 of 612 (57.8%) participants perceived ticks as a problem in their
community. Additionally, 364/611 (58.7%) respondents stated that CCHF is a problem in their
Table 1. Demographics of survey participants during an investigation of the 12 rural villages with
reporting at least one 2014 Crimean-Congo hemorrhagic fever case from January to September 2014
in Georgia.
Characteristics Median (IQR) Range
Age, years (n = 613) 54.8 (26.5) 18.6–101.4
Characteristics n % † 95% CI‡
Gender (n = 618)
Male 215 48.8 44.6–53.1
Ethnicity (n = 613)
Georgian 544 89.3 88.3–90.3
Azeri 55 8.7 8.1–9.4
Other 14 2.0 0.7–2.7
Occupation (n = 618)
Agriculture 289 47.1 42.9–51.3
Housework 160 21.1 17.9–24.1
Farmer 62 11.1 8.3–13.9
Office worker 45 7.4 5.2–9.6
Herder 4 0.7 0.0–1.4
Healthcare worker 3 0.4 0.0–0.8
Veterinarian 2 0.4 0.0–0.9
Slaughterhouse worker 0 0.0 -
Butcher 0 0.0 -
Other 53 11.8 8.8–14.9
Education (n = 617)
Elementary 36 5.6 3.7–7.4
Secondary 333 54.6 50.5–58.7
Vocational 126 20.1 16.8–23.4
Higher 117 19.1 15.8–22.3
Other 5 0.6 0.1–1.3
Monthly Income, US
Dollars (n = 616)
<50 64 10.1 7.7–12.6
50–250 453 73.9 70.3–77.5
251–500 88 14.3 11.5–17.2
>501 8 1.1 0.3–1.9
Don’t know 3 0.5 0.0–1.2
Land Ownership
(n = 612)
Rent 3 0.4 0.0–0.9
<1000m2 181 28.5 24.8–32.1
1000-2000m2 171 26.9 23.3–30.7
2001-3000m2 40 7.1 4.9–9.3
>3001m2 217 37.1 32.9–41.1
IQR: Interquartile range.
†Weighted percentage.
‡CI: Confidence interval.
doi:10.1371/journal.pone.0158049.t001
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Table 2. Knowledge of Crimean-Congo hemorrhagic fever (CCHF) among survey participants during an investigation of the 12 rural villages
reporting at least one 2014 CCHF case from January to September 2014 in Georgia.
All responses Correct responses
Knowledge n %* 95% CI† n %* 95% CI†
Transmission
(n = 429)‡
348 79.5 75.4–83.5
Tick bite 330 74.8 70.4–79.2
Crushing a tick
with bare hands
120 27.8 23.4–32.2
Infected animal
blood
65 15.5 11.8–19.2
Infected animal
bodily fluids
13 3.4 1.4–5.4
Raw meat 14 3.5 1.5–5.5
Infected humans 4 0.9 0.0–1.8
Unpasteurized milk 7 1.7 0.4–2.9
Other 10 2.6 0.9–4.2
Don’t know 74 18.5 14.6–22.3
High-risk activities
(n = 429)‡
349 80.3 76.3–84.4
Working with
livestock
317 73.1 68.7–77.6
Agriculture 203 46.3 41.4–51.2
Slaughtering 27 7.0 4.2–9.8
Butchering 29 7.3 4.5–10.0
Veterinarian 4 0.9 0.0–1.9
Healthcare 2 0.4 0.0–0.9
Other 9 2.3 0.7–3.8
Don’t know 78 18.9 14.9–22.9
Signs/Symptoms
(n = 429)‡
290 65.7 60.9–70.4
Fever 278 62.5 57.7–67.3
Headache 138 32.1 27.4–36.8
Nausea/vomiting 123 27.1 22.8–31.3
Diarrhea 10 2.0 0.7–3.2
Muscle Pain 33 8.6 5.6–11.6
Joint Pain 25 5.5 3.3–7.6
Weakness 48 9.9 7.1–12.6
Bruising 17 4.4 2.2–6.6
Bleeding/
hemorrhage
12 2.3 1.0–3.7
Other 44 8.8 6.2–11.5
Don’t know 137 33.7 29.1–38.4
Protection
Measures
(n = 612)
184 28.8 25.1–32.6
Yes 286 45.9 41.7–50.1
No 82 13.1 10.4–15.9
Don’t know 244 41.0 36.9–44.9
*Weighted percentage.
†CI: Confidence interval.
‡Multiple answers possible.
doi:10.1371/journal.pone.0158049.t002
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community (Table 3). Of 613 responding, 56.8% were concerned about contracting CCHF but
were equally likely to be engaged in CCHF high-risk activities compared with the 19.3% who
were not concerned (p = 0.5302).
Of 618 participants responding, 565 (91.5%) reported involvement in at least one known
CCHF high-risk activity (median: 2.6 activities, IQR 0.1, range: 0–7); there was no difference
among gender (p = 0.5299). Of 605 respondents, 477 (79.3%) reported involvement in agricul-
ture. Additionally, 434 (69.9%) respondents reported participation in animal husbandry; of
those, 339 (78.6%) owned cattle. Of 389 (63.3%) participants who reported tick exposures, 286
(46.7%) handled ticks bare-handed; 65 (29.7%) of 216 answering knew the associated risk. Of
605 respondents, 355 (57.9%) reported animal blood exposures; 32 (12.7%) of 281 answering
knew the associated risk. Of 565 responding, 65 (13.7%) were involved in animal births; of
those, 36 (55.6%) did not use personal protective equipment (Table 4).
In terms of CCHF preventive practices, 339/599 (57.3%) respondents denied employing
personal protective measures against CCHF and tick exposures. Of the 202 who knew and
employed personal protective measures, the most common method (84.5%) was using personal
protective equipment, defined as wearing long, covered clothing and gloves. Of 404 respond-
ing, 370 (92.1%) employed a protective measure to prevent ticks for their animals; 83.4% used
insecticides. For tick removal, of the 324 participants who removed ticks from their animals,
111 (35.0%) removed the ticks using bare hands. Of the 234 respondents that reported having
ticks on their body, 193 (81.1%) also removed the ticks with bare hands (Table 5).
Table 3. Attitudes regarding Crimean-Congo hemorrhagic fever (CCHF) and ticks among survey par-
ticipants during an investigation of the 12 rural villages reporting at least one 2014 CCHF case from
January to September 2014 in Georgia.
Attitude n %* 95% CI†
People frequently get
tick bites in the
community (n = 614)
Yes 199 31.7 28.1–35.3
No 165 26.9 23.2–30.5
Don't know 250 41.4 37.4–45.4
Ticks are a problem in
the community (n = 612)
Yes 359 57.8 53.9–61.7
No 87 15.8 12.7–18.9
Don't know 166 26.4 22.9–29.8
CCHF is a problem in
the community (n = 611)
Yes 364 58.7 54.8–62.6
No 57 9.8 7.3–12.3
Don't know 190 31.5 27.8–35.2
CCHF is something I
am worried about
(n = 613)
Yes 355 56.8 52.8–60.8
No 114 19.3 16.1–22.6
Don't know 144 23.9 20.4–27.4
*Weighted percentage.
†CI: Confidence interval.
doi:10.1371/journal.pone.0158049.t003
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Serosurvey
Of 643 people approached and eligible, 444 (69.1%) consented to the CCHF serosurvey. Of the
110 participants that provided a reason for refusal, 63 (57.3%) stated they were “too scared” of
the needle. Additionally, five participants were unable to provide a sample due to poor venous
access. Thus, 439 samples underwent laboratory analysis (0.9 samples per household). Of
these, one participant consented for blood and not the survey, one survey was missing in the
field, and two blood specimens were mislabeled. As such, survey data were available for 435
participants for analysis.
In total, 12 (2.8%) samples were anti-CCHF IgG positive, indicating past infection within four
months to five years prior, and one (0.2%) was anti-CCHF IgM positive, indicating recent infec-
tion (1,2). On further examination, the anti-CCHF IgM positive participant was asymptomatic,
as well as RT-PCR and anti-CCHF IgG negative. The participant remained asymptomatic and
had similar laboratory results on repeat testing four months after initial testing, indicating a false-
positive. Thus, only the 12 anti-CCHF IgG positive cases underwent analysis. When controlled
for gender and non-response, the seroprevalence was weighted to 3.0% (CI: 1.2–4.8).
The seropositive subjects were located in six (50.0%) of the 12 villages tested (Fig 2). Seven
(58.3%) seropositive participants were male. Median seropositive subjects’ age was 71.2 years
(IQR: 18.3, range: 49.8–84.9). Most (66.6%) reported an agrarian occupation (Table 6).
Seropositive subject’s most common CCHF high-risk activity was tick exposure (66.7%);
there was no significant difference compared to seronegative subjects’ tick exposure (OR: 1.0,
CI: 0.3–3.4, p = 0.7696). Other CCHF high-risk activities included agriculture (58.3%), animal
husbandry (58.3%), and herding (33.3%). Additionally, there was no difference in the median
of high-risk activities among the seropositive subjects (median = 3.0 activities, IQR: 4, range:
0–6) compared to the seronegative subjects (median = 3.0 activities, IQR: 2, range: 0–7,
p = 0.8257).
In the four months preceding the survey, four (33.3%) seropositive subjects reported fever
and muscle pain; of those, one also reported concomitant jaundice and one reported concomi-
tant bruising. None of the seropositive subjects reported symptoms during the prior four
months to five years’ timeframe.
Table 4. Crimean-Congo hemorrhagic fever (CCHF) high-risk activities among survey participants
during an investigation of the 12 rural villages reporting at least one 2014 CCHF case from January to
September 2014 in Georgia.
High-Risk Activities n %* 95% CI†
Agriculture (n = 605) 477 79.3 75.9–82.8
Animal husbandry
(n = 618)
434 69.9 66.3–73.6
Tick exposure (n = 618) 389 63.3 59.5–67.1
Butchering raw meat
(n = 603)
334 53.4 49.3–57.5
Herding (n = 585) 102 20.3 16.7–23.8
Animal births (n = 565) 65 13.7 10.5–16.9
Slaughtering (n = 603) 42 7.9 5.5–10.2
Drinking unpasteurized
milk (n = 602)
36 5.9 4.0–7.7
Healthcare settings
(n = 604)
2 0.3 0.0–0.7
*Weighted percentage.
†CI: Confidence interval.
doi:10.1371/journal.pone.0158049.t004
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Discussion
In response to the high CCHF case count detected in 2014, this investigation identified and
characterized the CCHF risk factors, gaps in CCHF-related knowledge and practices, as well as
the prevalence of the disease in the communities reporting 2014 CCHF cases, to inform imme-
diate public health interventions. Overall, participants in all villages were found to be at high-
risk for CCHF transmission, as most were engaged in known CCHF high-risk activities. More
specifically, ticks were found to be a common high-risk exposure in these villages through
activities associated with agriculture and animal husbandry.
Most participants heard of CCHF before the investigation, which translated into knowledge
regarding CCHF transmission, CCHF high-risk activities, and CCHF-related signs and
Table 5. Tick prevention and removal practices among survey participants during an investigation of
the 12 rural villages reporting at least one 2014 Crimean-Congo hemorrhagic fever case from January
to September 2014 in Georgia.
Human-tick interaction n %* 95% CI†
Method to prevent
(n = 599)‡
Nothing 339 57.3 53.2–61.3
Personal protective
equipment§
172 28.0 24.3–31.7
Pesticides 25 4.9 2.9–6.9
Repellent 10 1.7 0.6–2.8
Avoid woody/rural areas 8 1.5 0.4–2.6
Other 15 2.5 1.4–4.1
Don't know 58 9.6 7.2–11.9
Method to Remove
Ticks (n = 234)
Bare hands 193 81.8 76.4–87.3
Use an object 21 8.6 4.7–12.4
Gloves 5 2.3 0.2–4.4
Hospital 2 0.7 0.0–1.6
Other 13 6.7 2.9–10.4
Animal-tick interaction n %* 95% CI†
Method to prevent
(n = 404)‡
Insecticides 338 83.4 75.5–87.2
Nothing 34 7.9 5.3–10.6
Injectable 20 5.6 3.1–7.9
Other 25 6.4 3.8–8.9
Method to remove ticks
(n = 324)
Pour insecticides 184 56.5 50.8–62.2
Bare hands 111 35.0 29.5–40.5
Object 20 5.8 3.2–8.5
Veterinarian 3 1.0 0.0–1.9
Other 6 1.7 0.3–3.1
*Weighted percentage.
†CI: Confidence interval.
‡Multiple answers possible.
§Includes wearing long, covered clothing and gloves.
doi:10.1371/journal.pone.0158049.t005
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symptoms, but gaps in knowledge were still evident. Although most were aware that a tick bite
was a means of CCHF transmission, very few knew that crushing a tick with bare hands was
also a risk. Even those participants who engaged in high-risk activities, specifically those who
handled ticks bare handed and had animal blood exposures, were unaware of the associated
CCHF risk. Thus, it is important that educational campaigns are employed in these villages,
targeting the specific sub-groups that are engaged in theses high-risk activities, including herd-
ers, agricultural workers, slaughterhouse workers, and veterinarians.
In addition to lack of knowledge regarding CCHF high-risk activities, the data revealed a
major gap in the knowledge of and employment of personal protective measures against CCHF.
Only a few participants correctly knew CCHF protective measures and of those, only half actually
employed the measures. This indicates that knowledge did not translate into risk avoidance in
these communities; although likely multifactorial in nature, this may be due to a reliance on these
high-risk activities for livelihoods. As personal protection knowledge is lacking in these commu-
nities, as well as the employment of these measures, this topic should be highlighted in educa-
tional campaigns targeting these communities. Additionally, although risk factor avoidance
should be discussed as a possible intervention, educational campaigns should highlight the
employment of protection methods, as avoidance may not be possible in these communities.
The serosurvey revealed a 3.0% weighted seroprevalence of past CCHF exposure in these
villages, which is consistent with reports in neighboring countries [4, 9, 10, 15–17]. Addition-
ally, the data revealed possible subclinical cases of CCHF, as most did not report any symptoms
Fig 2. Geographic distribution of Crimean-Congo hemorrhagic fever (CCHF) seropositive participants among survey participants during an
investigation of the 12 rural villages reporting at least one 2014 CCHF case from January to September 2014 in Georgia.Georgia is demarcated in
white with surrounding countries in gray. The capital, Tbilisi, is indicated by a star. Circle size indicates the number of seropositive subjects in that area; the
bigger the circle, the higher the number of seropositive subjects. Map adapted fromMapsOpenSource.com.
doi:10.1371/journal.pone.0158049.g002
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consistent with CCHF in the previous five years, corresponding to the time when anti-CCHF
IgG remains detectable [1,2]. This is consistent with findings from a previous study document-
ing that only about one of five people infected with CCHF develop symptoms [3].
Although the surveillance system, EIDSS, uses anti-CCHF IgM to confirm acute infection
and this investigation found positive anti-CCHF IgG subjects, demonstrating infection
Table 6. Crimean-Congo hemorrhagic fever (CCHF) seropositive subjects’ demographics among sur-
vey participants during an investigation of the 12 rural villages reporting at least one 2014 CCHF case
from January to September 2014 in Georgia (N = 12).
Characteristics Median (IQR) Range
Age, years 71.2 (18.3) 49.8–84.9
Characteristics n % 95% CI†
Gender
Male 7 58.3 27.7–84.8
Ethnicity
Georgian 9 75.0 42.8–94.5
Azeri 2 16.7 2.1–48.4
Other 1 8.3 0.2–38.5
Occupation
Gardening 6 50.0 21.1–78.9
Housework 2 16.7 2.1–48.4
Farmer 1 8.3 0.2–38.5
Herder 1 8.3 0.2–38.5
Office 0 0.0 -
Slaughterhouse Worker 0 0.0 -
Butcher 0 0.0 -
Healthcare Worker 0 0.0 -
Veterinarian 0 0.0 -
Other 2 16.7 2.1–48.4
Education
Elementary 4 33.3 9.9–65.1
Secondary 4 33.3 9.9–65.1
Vocational 3 25.0 5.5–57.2
Higher 1 8.3 0.2–38.5
Other 0 0.0 -
Monthly Income, US
Dollars
<50 1 8.3 0.2–38.5
51–250 10 83.3 51.6–97.9
251–500 1 8.3 0.2–38.5
>501 0 0.0 -
Land Ownership
Rent 0 0.0 -
<1000m2 0 0.0 -
1000-2000m2 5 41.7 15.2–72.3
2001-3000m2 1 8.3 0.2–38.5
>3001m2 6 50.0 21.1–78.9
IQR: Interquartile range.
†CI: Confidence interval.
doi:10.1371/journal.pone.0158049.t006
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sometime within the last five years, comparisons can still be made; EIDSS had been operating
for five years prior to this investigation, within the limit of the anti-CCHF IgG seropositivity;
thus, the surveillance system had the opportunity to capture these cases. Additionally, both
EIDSS and this investigation used the same ELISA commercial kits ensuring consistency of the
specificity and sensitivity of the testing assay used.
Overall, the seroprevalence in these villages is higher than what had been previously
detected, 0.03%, by the surveillance system. Two factors likely underlie this discrepancy: one is
the existence of subclinical cases, as most seropositive subjects did not report any symptoms
associated with CCHF, and thus, would not be captured in EIDSS. Second, there may be issues
with physicians’ recognition of CCHF signs/symptoms, as the four seropositive participants
who had symptoms consistent with CCHF were not captured in EIDSS. These findings high-
light the importance of continuing to improve physicians’ awareness of milder presentations of
CCHF in these communities. Additionally, this underreporting will need to be considered
when reporting CCHF in Georgia in the future.
There were a number of limitations to this investigation. First, summer homes were not
included in this evaluation and thus, data cannot be extrapolated to this population. Neverthe-
less, this population may also have similar risk factors as they likely populate the homes during
months with known increased tick activity, which should be considered when timing future
public health interventions [22]. Second, data from this investigation can only be extrapolated
to the population in the villages surveyed, not the country of Georgia. As this was an emer-
gency investigation of the villages reporting CCHF cases in 2014 to dictate immediate public
health interventions in these specific villages, other villages were not surveyed as controls.
Thus, although these results cannot be generalized to other villages in Georgia, it raises the
question whether this high prevalence of CCHF high-risk activities and seropositivity is unique
to these investigated villages or whether these findings exist beyond the village borders. As
these data trends may occur in other villages with similar characteristics and demographic pro-
files (located along herding routes and/or where agrarian activities are the mainstay of liveli-
hood), it is important to consider expansion of previous educational campaigns to other
similar villages. Third, females were overrepresented in the survey population. It is possible
that this is a result of conducting the survey during daylight hours when men were more likely
to be engaged in agricultural activities outside of the home. In an effort to address this limita-
tion, we weighted our data analysis by gender. Fourth, the evaluation of clinical symptoms of
the seropositive participants may be limited due to recall bias. Therefore, there may have been
symptoms at the time of a respondent’s infection with the CCHF virus that were not remem-
bered during survey administration. And finally, analysis of the serosurvey data was limited as
the sample size goal was not obtained. Thus, there may be significant trends, including differ-
ences in exposures to high-risk activities between the seropositive subjects and seronegative
subjects that are not revealed in this investigation due to insufficient power.
Even in light of these limitations, this investigation identified large gaps in CCHF-related
knowledge and the use of preventive practices in the setting of a high prevalence of CCHF
high-risk activities and seropositivity in these villages; these findings are critical to informing
public health interventions in these communities, specifically the importance of employing
educational campaigns tailored to the gaps highlighted in this investigation, targeting both
community members as well as physicians. Additionally, the identification of a higher CCHF
seroprevalence in these villages than previously detected highlights the importance of support-
ing ongoing CCHF investigations in Georgia, as well as continuing efforts to improve the sur-
veillance system’s sensitivity. Finally, although the investigation only took place in specific
villages in the country of Georgia, this is the first large scale CCHF investigation in the country.
Thus, this investigation not only contributes to the previously limited knowledge regarding
Georgia Crimean-Congo Hemorrhagic Fever Study
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CCHF in the country of Georgia, but also contributes to the larger understanding of the overall
regional prevalence of the disease.
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